D. Mirejovsky

发表

Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.

R. Crooke, P. Felgner, J. Felgner, 1998, Journal of drug targeting.

MO‐SCF calculations on protonated butatriene and 1,2,3‐pentatriene

D. Mirejovsky, W. Drenth, F. B. Duijneveldt, 2010 .

Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin given intravesically.

J. Schellens, H. Rosing, J. Beijnen, 2008, Rapid communications in mass spectrometry : RCM.

Water properties of hydrogel contact lens materials: a possible predictive model for corneal desiccation staining.

D. Mirejovsky, G. Young, A. Patel, 1993, Biomaterials.

Effect of proteins on water and transport properties of various hydrogel contact lens materials.

D. Mirejovsky, A. Patel, D. D. Rodriguez, 1991, Current eye research.

HEAT CAPACITIES OF SOLUTION FOR ALCOHOLS IN POLAR SOLVENTS AND THE NEW VIEW OF HYDROPHOBIC EFFECTS

D. Mirejovsky, E. Arnett, Edward M. Arnett, 1983 .

Lipid Adsorption onto Hydrogel Contact Lens Materials. Advantages of Nile Red over Oil Red O in Visualization of Lipids

D. Mirejovsky, Archana Patel, T. J. Hunt, 1991, Optometry and vision science : official publication of the American Academy of Optometry.

Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum. An X-ray diffraction study.

S. White, G. I. King, D. Mirejovsky, 1988, Biochemistry.

Development of a bladder instillation of the indoloquinone anticancer agent EO-9 using tert-butyl alcohol as lyophilization vehicle

J. Beijnen, D. Mirejovsky, F. Flesch, 2007, AAPS PharmSciTech.

Complexation Study of the Anticancer Agent EO-9 with 2-hydroxypropyl-β-Cyclodextrin

J. Beijnen, D. Mirejovsky, F. Flesch, 2008 .

EO-9 bladder instillations: formulation selection based on stability characteristics and in vitro simulation studies.

J. Beijnen, D. Mirejovsky, B. Nuijen, 2007, International journal of pharmaceutics.

Simultaneous Quantitative Analysis of EO9 (Apaziquone) and its Conversion Products EO5a and EO9-Cl in Human and Dog Urine by High-Performance Liquid Chromatography Coupled with Electrospray Tandem Mass Spectrometry

J. Schellens, H. Rosing, J. Beijnen, 2009 .

Stability experiments in human urine with EO9 (apaziquone): a novel anticancer agent for the intravesical treatment of bladder cancer.

J. Schellens, H. Rosing, J. Beijnen, 2007, Journal of pharmaceutical and biomedical analysis.

Quantitative analysis of EO9 (apaziquone) and its metabolite EO5a in human plasma by high-performance liquid chromatography under basic conditions coupled to electrospray tandem mass spectrometry.

J. Schellens, H. Rosing, J. Beijnen, 2006, Journal of mass spectrometry : JMS.

Analysis of NAD(P)H:quinone oxidoreductase-1 (NQO1), Cytochrome P450 Oxidoreductase (P450R) and Glucose transporter 1 (Glut-1) protein expression suggests a possible role for EO9 in the treatment of invasive bladder cancer

R. Wheelhouse, D. Mirejovsky, R. Phillips, 2006 .

A hypothesis for the aetiology of soft contact lens-induced superior arcuate keratopathy

D. Mirejovsky, G. Young, 1993 .